The government will pause prescribing puberty blockers to young people with gender dysphoria while awaiting results from the UK's clinical trial, keeping existing youth gender services, and strengthening safeguards to ensure treatments are clinically sound and in children's best interests.
🌟 Be the first to share your thoughts!
